Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers
- 31 December 1992
- journal article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 4 (5), 647-655
- https://doi.org/10.1016/0952-7915(92)90041-c
Abstract
The initial promise of monoclonal antibodies as major therapeutic agents in human epithelial cancer has not been realized. Inaccessibility of cells in solid tumors due to factors such as the nature of the vascular endothelia and high pressure in the tumor are primarily responsible for the failure of antibody therapy. Although new strategies employing recombinant antibodies and immunoglobulins designed to actively engage the immune system may prove beneficial, micrometastatic tumor cells (at the stage of minimal residual disease) are likely to be the only suitable targets for antibody therapy. The diagnostic approaches to identify and characterize these cells and their use for prognosis and monitoring adjuvant immunotherapy is discussed.Keywords
This publication has 36 references indexed in Scilit:
- An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumoursInternational Journal of Cancer, 1992
- Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significanceEuropean Journal of Cancer and Clinical Oncology, 1991
- Recombinant Toxins for Cancer TreatmentScience, 1991
- A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer, 1991
- The control of homologous lysisImmunology Today, 1991
- Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodiesCancer Immunology, Immunotherapy, 1991
- Two monoclonal antibodies against small-cell lung cancer show existence of synergism in bindingCancer Immunology, Immunotherapy, 1991
- Anti-Idiotype Monoclonal Antibodies as Vaccines for Human CancerInternational Reviews of Immunology, 1991
- Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC)International Journal of Cancer, 1988
- MONOCLONAL ANTIBODIES TO EPITHELIAL MEMBRANE ANTIGEN AND HUMAN MILK FAT GLOBULE MUCIN DEFINE EPITOPES EXPRESSED ON OTHER MOLECULESThe Lancet, 1985